-
A Regulatory NADH/NAD+ Redox Biosensor for Bacteria
2026-09-15
Liu, Landick, and Raman developed a Rex-regulated genetically encoded biosensor for monitoring bacterial NADH/NAD+ redox state in living cells. The study linked promoter and operator engineering to measurements of respiratory-chain mutants, carbon-source effects, and pooled screening, demonstrating that the system can reveal redox phenotypes that are difficult to capture with conventional assays.
-
Indomethacin Workflows for Adipose and Inflammation
2026-09-15
Indomethacin provides a practical pharmacological perturbation for separating cyclooxygenase, PPAR, lipid, and membrane effects in cell-based assays. This workflow also shows how to use it alongside SEMA3E and β-catenin experiments without mistaking a broad small-molecule response for pathway-specific proof.
-
EZ Cap EGFP mRNA 5-moUTP: Workflow Guide
2026-09-14
Build cleaner reporter experiments with Cap1-capped, 5-moUTP-modified EGFP mRNA for delivery benchmarking, translation analysis, and fluorescence imaging. This workflow emphasizes controlled dosing, compatible complex formation, quantitative readouts, and troubleshooting before a therapeutic payload is tested.
-
6-FAM SE: From Labeling Chemistry to Translation
2026-09-14
6-FAM SE combines amine-directed NHS-ester chemistry with durable fluorescein labeling, creating a practical bridge between molecular assays and translational nanomedicine characterization. This article explains the mechanism, workflow controls, competitive advantages, and responsible use of 6-FAM SE in research inspired by glutathione-responsive melanoma nanoparticles.
-
Amikacin (BAY416651) Resistance Workflow
2026-09-13
Build a reproducible Amikacin workflow for susceptibility testing, carbapenemase-linked resistance profiling, and plasmid transmission studies. This guide combines product handling with practical assay decisions for Enterobacter cloacae and Klebsiella pneumoniae research.
-
Cycloheximide for RNA–Protein Causality Studies
2026-09-12
Cycloheximide is a protein biosynthesis inhibitor that can sharpen causal analysis of RNA stability, translation, and protein turnover. This guide connects translational control with the FTO–MTUS1/ATIP1 axis while emphasizing assay design, controls, and interpretation limits.
-
SEMA3E, β-Catenin, and Beige Adipocyte Thermogenesis
2026-09-11
A 2026 mouse study identifies SEMA3E as a positive regulator of beige adipocyte differentiation and non-shivering thermogenesis, linking its activity to mitochondrial oxidative phosphorylation and β-catenin signaling. The work combines genetic perturbation, adipose transplantation, AAV-mediated knockdown, transcriptomics, and mitochondrial respiration assays to establish a mechanistic framework for studying adipose tissue plasticity.
-
Golgi-Tracker Green for Live Golgi Imaging
2026-09-11
Golgi-Tracker Green is a BODIPY FL-labeled C5-ceramide probe for selective Golgi labeling in live cells. Its reported photostability, solvent compatibility, and live-cell restriction support Golgi apparatus imaging, lipid transport pathway visualization, and sphingolipid metabolism analysis.
-
Indomethacin Workflows for Inflammation Research
2026-09-10
Indomethacin supports controlled dissection of cyclooxygenase activity, PPAR-linked transcription, lipid handling, and membrane organization in cell-based assays. This practical guide connects dose design and assay controls with the FXR–KLF11 findings reported in contrast-induced kidney injury research, while clearly separating established evidence from exploratory use.
-
Quaternization Reprograms Lung-Targeted mRNA Delivery
2026-09-10
The 2024 Theranostics study shows that N-quaternization of a lipid-like compound can convert systemic mRNA delivery from spleen accumulation to highly selective lung targeting. Its findings identify head-group chemistry as a relatively simple design variable for directing pulmonary delivery, while also highlighting the importance of cell-specific uptake, storage stability, and translation readouts.
-
Serine/Glycine-Free Diet and PD-L1 Lactylation
2026-09-09
A 2024 Cell Metabolism study shows that a serine/glycine-free diet can suppress colorectal cancer growth and increase cytotoxic T-cell accumulation, while also enabling immune evasion through PD-L1 lactylation. The work links dietary metabolism to checkpoint regulation and provides early clinical evidence that the intervention is feasible and safe, although combination with immunotherapy requires further validation.
-
Nebivolol Hydrochloride as an Assay Control
2026-09-09
Nebivolol hydrochloride is more than a selective β1-adrenoceptor antagonist: it can help researchers separate receptor-mediated cardiovascular biology from unrelated mTOR effects. This article translates a yeast-based mTOR screening study into practical assay design, controls, and interpretation strategies.
-
EZ Cap™ EGFP mRNA: Practical Workflow Guide
2026-09-08
EZ Cap™ EGFP mRNA provides a Cap 1 EGFP reporter mRNA input for evaluating delivery and expression in research systems. It is suitable for controlled reporter workflows, but the supplied dossier does not establish a universal dose, cell type, readout window, or performance outcome.
-
Nebivolol hydrochloride for β1 Signaling Assays
2026-09-08
Nebivolol hydrochloride combines nanomolar β1-adrenoceptor selectivity with a useful negative result in a sensitized yeast mTOR screen. This makes it valuable for separating cardiovascular receptor biology from TOR-pathway effects while improving assay controls, dosing logic, and troubleshooting.
-
Esflurbiprofen and SERT-nNOS in Rapid Antidepressant Action
2026-09-07
The reference study identifies esflurbiprofen as a preclinical fast-onset antidepressant candidate that disrupts the SERT-nNOS complex in the dorsal raphe nucleus. Its combination of mBRET screening, stress-model pharmacology, and rs-fMRI links a molecular interaction to serotonergic circuit and behavioral changes, while also defining important limits for translation beyond mice.